CIK 0000917520 · Large accelerated filer
INTEGRA LIFESCIENCES HOLDINGS CORP
Sign in to watch- Ticker
- IART
- Exchange
- Nasdaq
- Industry
- Surgical & Medical Instruments & Apparatus
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 510317849
- Phone
- 6092750500
- Business address
- 1100 CAMPUS ROAD, PRINCETON, NJ, 08540
- Former names
- INTEGRA LIFESCIENCES CORP
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2024-03-06 | DAVIS ROBERT T. JR. EVP & President, TT | Option exercise · Non-Qualified Stock Option (right to buy) | −8,736 | 0 | ||
| 2024-02-20 | McBreen Michael J. EVP & President, CSS | Grant or award | +3,516 | 45,968 | ||
| 2024-02-20 | Mosebrook Jeffrey SVP, Fin & Princ Acct Officer | Grant or award | +808 | 24,266 | ||
| 2024-02-20 | Schwartz Eric EVP, Chief Legal Officer & Sec | Grant or award | +2,564 | 51,161 | ||
| 2024-02-20 | DAVIS ROBERT T. JR. EVP & President, TT | Grant or award | +3,721 | 49,505 | ||
| 2024-01-18 | De Witte Jan President & CEO | Option exercise | +597 | 18,947 | ||
| 2024-01-18 | De Witte Jan President & CEO | Shares withheld for taxes | −597 | $42.39 | $25K | 18,350 |
| 2024-01-18 | De Witte Jan President & CEO | Option exercise · Restricted Stock Units | −597 | 89,417 | ||
| 2023-12-12 | GRAVES JEFFREY A Director | Grant or award | +2,216 | 2,216 | ||
| 2023-11-01 | De Witte Jan President & CEO | Option exercise | +9,814 | 22,612 | ||
| 2023-11-01 | De Witte Jan President & CEO | Shares withheld for taxes | −4,262 | $36.85 | $157K | 18,350 |
| 2023-11-01 | De Witte Jan President & CEO | Option exercise · Restricted Stock Units | −9,814 | 90,014 | ||
| 2023-09-01 | Veillon-Berteloot Chantal EVP & CHRO | Grant or award | +4,678 | 4,678 | ||
| 2023-09-01 | Veillon-Berteloot Chantal EVP & CHRO | Grant or award | +9,355 | 14,033 | ||
| 2023-08-09 | Mosebrook Jeffrey SVP, Fin & PAO | Sale | −1,177 | $44.46 | $52K | 23,458 |
| 2023-07-03 | Knight Lea Daniels EVP & CFO | Grant or award | +18,293 | 18,293 | ||
| 2023-07-03 | Knight Lea Daniels EVP & CFO | Grant or award | +6,098 | 24,391 | ||
| 2023-07-03 | Mosebrook Jeffrey SVP, Fin & PAO | Grant or award | +12,196 | 24,635 | ||
| 2023-06-01 | Schwartz Eric EVP, Chief Legal Officer & Sec | Purchase | +2,640 | $37.89 | $100K | 48,597 |
| 2023-06-01 | De Witte Jan President & CEO | Purchase | +7,792 | $38.50 | $300K | 12,798 |
Page 10 of 11 · 211 trades